Sonic Healthcare (ASX:SHL) will acquire LADR - Laboratory Group Dr. Kramer & Colleagues in Germany for 423 million euros, according to a Monday filing with the Australian bourse.
The transaction consideration includes the issue of up to 222 million euros in Sonic Healthcare ordinary shares, the filing said. The balance will be settled via existing cash and debt facilities.
Sonic Healthcare expects the acquisition to be immediately accretive to earnings per share, reaching high single-digit percentage accretion after three years, the filing stated.
The deal is expected to close in the first half of 2025, subject to conditions and regulatory approval.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。